We only have this paper's title and publication details.
Read it at the sourceResearch demonstrates USP15 promotes immune evasion in colorectal cancer, suggesting implications for treatment targeting SMYD3 and CCL2.
USP15 is upregulated and correlates with poor prognosis in CRC.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: